Pyoderma gangrenosum with liver, spleen and bone involvement in a patient with chronic myelomonocytic leukaemia

M Vadillo; A Jucgla; D Podzamczer; G Rufi; A Domingo

doi:10.1046/j.1365-2133.1999.03055.x

Pyoderma gangrenosum with liver, spleen and bone involvement in a patient with chronic myelomonocytic leukaemia

Br J Dermatol. 1999 Sep;141(3):541-3. doi: 10.1046/j.1365-2133.1999.03055.x.

Authors

M Vadillo¹, A Jucgla, D Podzamczer, G Rufi, A Domingo

Affiliation

¹ Department of Infectious DiseaseDermatology, Hospital Prínceps d'Espanya, Ciutat Sanitària i Universitària de Bellvitge, Department de Medicina, Universitat de Barcelona, L'hospitalet de Llobregat, Spain.

PMID: 10583064
DOI: 10.1046/j.1365-2133.1999.03055.x

Abstract

Pyoderma gangrenosum is a neutrophilic dermatosis of unknown aetiology. Visceral involvement by pyoderma gangrenosum is rare, the lung being the most frequent site of extracutaneous disease. We describe a 73-year-old man with pyoderma gangrenosum and chronic myelomonocytic leukaemia in whom aseptic hepatosplenic abscesses and bony lesions were associated.

Publication types

Case Reports

MeSH terms

Abscess / complications
Abscess / drug therapy
Aged
Anti-Inflammatory Agents / therapeutic use
Bone Diseases / complications*
Bone Diseases / drug therapy
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
Liver Abscess / complications*
Liver Abscess / drug therapy
Male
Prednisone / therapeutic use
Pyoderma Gangrenosum / complications*
Pyoderma Gangrenosum / drug therapy
Pyoderma Gangrenosum / pathology*
Splenic Diseases / complications*
Splenic Diseases / drug therapy

Substances

Anti-Inflammatory Agents
Prednisone